Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Acta Radiologica. Supplementum
|
January 1, 1991
Endogenous 211At alpha-particle radiotherapy for undifferentiated thyroid cancer
I Brown, R N Carpenter
The Journal of the Acoustical Society of America
|
April 1, 1984
An improvement in the range resolution of ultrasonic pulse echo systems by deconvolution
R N Carpenter, P R Stepanishen
Cancer Research
|
May 15, 1990
211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of micrometastases
E M Link, R N Carpenter
Cancer Research
|
August 15, 1992
211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of cutaneous tumors and lymph node metastases
E M Link, R N Carpenter
Experientia
|
March 15, 1983
alpha-Particle track autoradiography for localization of a 211At-astatinated drug
J S Mitchell, I Brown, R N Carpenter
Strahlenschutz in Forschung Und Praxis
|
January 1, 1985
[The development of new radioactive drugs with a high LET radiation against cancer]
J S Mitchell, I Brown, R N Carpenter
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
The development of A [211At]-astatinated endoradiotherapeutic drug: Part I. Localization by alpha-particle autoradiography in a murine tumor model
I Brown, R N Carpenter, J S Mitchell
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1983
The in vitro selective concentration of an 125I-iodinated compound in human tumor cells
R N Carpenter, I Brown, J S Mitchell
The International Journal of Applied Radiation and Isotopes
|
September 1, 1984
Biodistribution of 6-[211At]astato-2-methyl-1,4-naphthoquinol bis(diphosphate salt) and 211At- in mice with a transplanted rectal adenocarcinoma
I Brown, R N Carpenter, J S Mitchell
European Journal of Nuclear Medicine
|
January 1, 1982
6-125I-iodo-2-methyl-1,4-naphthoquinol bis (diammonium phosphate) as a potential radio-halogenated anti-cancer agent: in vitro investigations and possible clinical implications
I Brown, R N Carpenter, J S Mitchell
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Acta Radiologica. Supplementum
|
January 1, 1991
Endogenous 211At alpha-particle radiotherapy for undifferentiated thyroid cancer
I Brown, R N Carpenter
The Journal of the Acoustical Society of America
|
April 1, 1984
An improvement in the range resolution of ultrasonic pulse echo systems by deconvolution
R N Carpenter, P R Stepanishen
Cancer Research
|
May 15, 1990
211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of micrometastases
E M Link, R N Carpenter
Cancer Research
|
August 15, 1992
211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of cutaneous tumors and lymph node metastases
E M Link, R N Carpenter
Experientia
|
March 15, 1983
alpha-Particle track autoradiography for localization of a 211At-astatinated drug
J S Mitchell, I Brown, R N Carpenter
Strahlenschutz in Forschung Und Praxis
|
January 1, 1985
[The development of new radioactive drugs with a high LET radiation against cancer]
J S Mitchell, I Brown, R N Carpenter
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
The development of A [211At]-astatinated endoradiotherapeutic drug: Part I. Localization by alpha-particle autoradiography in a murine tumor model
I Brown, R N Carpenter, J S Mitchell
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1983
The in vitro selective concentration of an 125I-iodinated compound in human tumor cells
R N Carpenter, I Brown, J S Mitchell
The International Journal of Applied Radiation and Isotopes
|
September 1, 1984
Biodistribution of 6-[211At]astato-2-methyl-1,4-naphthoquinol bis(diphosphate salt) and 211At- in mice with a transplanted rectal adenocarcinoma
I Brown, R N Carpenter, J S Mitchell
European Journal of Nuclear Medicine
|
January 1, 1982
6-125I-iodo-2-methyl-1,4-naphthoquinol bis (diammonium phosphate) as a potential radio-halogenated anti-cancer agent: in vitro investigations and possible clinical implications
I Brown, R N Carpenter, J S Mitchell
Page
of 2